Alnylam Pharmaceuticals Inc (DUL)
FSX
Real-time Data
06:00 AM
Day's Range
195.5552 wk Range
173.50Overview - DUL - Alnylam Pharmaceuticals Inc
Key Statistics
Valuation
Enterprise Value
22.85B
P/E (Trailing)
‪41.11‬
P/E (Forward)
‪-53.80‬
PEG Ratio
‪-0.12‬
Price / Sales (TTM)
‪5.63‬
Price / Book
‪23.11‬
EV / EBITDA
‪25.36‬
Profitability
Gross Margin
‪76.88%‬
Profit Margin
‪16.12%‬
Operating Margin
‪17.92%‬
Return on Assets
‪12.34%‬
Return on Equity
‪96.55%‬
Ownership
Shares Outstanding
133.73M
Float
133.23M
Held by Insiders
‪0.18%‬
Held by Institutions
‪101.71%‬
Price stats
Beta
‪0.27‬
50-Day Avg
‪233.27‬
200-Day Avg
‪280.89‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - DUL - Alnylam Pharmaceuticals Inc
Peers - DUL - Alnylam Pharmaceuticals Inc
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- DULFSXAlnylam Pharmaceuticals Inc27.06BMarket Cap-90.26%52-week change40.35P/E (Trailing)‪16.12%‬Profit Margin
- ANLFSXAnalog Devices, Inc.155.74BMarket Cap+33.03%52-week change44.47P/E (Trailing)‪29.78%‬Profit Margin
- 1AEFSXargenx SE54.66BMarket Cap+32.95%52-week change39.15P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt54.41BMarket Cap+34.86%52-week change38.91P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna, Inc.50.02BMarket Cap+82.32%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 42ZFSXRevolution Medicines Inc.38.84BMarket Cap+82.79%52-week change-30.46P/E (Trailing)‪0.00%‬Profit Margin
- 49BAFSXBeOne Medicines, Ltd. American Depositary Receipt35.97BMarket Cap+14.46%52-week change66.67P/E (Trailing)‪10.69%‬Profit Margin
Profile Summary - DUL - Alnylam Pharmaceuticals Inc
About
Alnylam Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing RNA interference (RNAi) therapeutics. This innovative gene silencing technology targets the root causes of diseases at the genetic level, offering potential treatments for rare and prevalent conditions across multiple…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
